Search Within

Kang Zhang

Formats
  1. Meeting Abstract (7)
Groups
  1. Cell Biology Program Faculty (7)
  2. Sloan Kettering Institute Faculty (7)
  3. Department of Medicine (3)
  4. Center for Hematologic Malignancies (2)
  5. Hematologic Malignancies, Division of (2)
  6. Lymphoma (2)

More Groups

People
  1. Malcolm Moore (7)
  2. Eunice Wang (3)
  3. Andrew Zelenetz (2)
  4. David Dorn (2)
  5. Kaida Wu (2)
  6. Owen O'connor (2)

More People

Years
  1. 2007 (1)
  2. 2005 (3)
  3. 2002 (2)
  4. 2001 (1)
Publications
  1. Blood (3)
  2. Cancer Research (3)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Hematology (3)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting Cdk4/6 in combination therapy overcomes proteasome inhibitor resistance in multiple myeloma through synergistic mitochondria depolarization
    Meeting Abstract

    Huang, X.; Louie, T.; Di Liberto, M.; Rice, J.; Jayabalan, D.; Zhang, K.; Palladino, M.; Chen, I.; Toogood, P.; Niesvizky, R.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • A humanized insulin-like growth factor I receptor antibody inhibits multiple myeloma cell growth in vivo through anti-angiogenesis
    Meeting Abstract

    Wu, K.; Zhou, L.; Zhang, K.; Burtrum, D.; Ludwig, D. L.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The migrastatins: A new family of metastatasis inhibitors
    Meeting Abstract

    Dorn, D. C.; Njardarson, J. T.; Mandal, M.; Gaul, C.; Kou, C.; Zhang, K.; Ponomarev, V.; Danishefsky, S. J.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Fludelone, an optimized epothilone for ovarian cancer treatment
    Meeting Abstract

    Dorn, D. C.; Cho, Y. S.; Procissi, D.; Liedtke, M.; Zhang, K.; Ponomarev, V.; Koutcher, J. A.; Danishefsky, S. J.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Inhibition of VEGFR2 mediated paracrine pathways suppresses non-Hodgkin's lymphoma xenograft growth in NOD/SCID mice
    Meeting Abstract

    Wang, E. S.; Zhang, K.; O'connor, O.; Zhu, Z.; Hicklin, D.; Witte, L.; Zelenetz, A.; Rafii, S.; Moore, M. A. S.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Treatment with GRN163 (novel telomerase template antagonist) selectively inhibits growth of myeloma and lymphoma cell lines and tumor xenografts by inducing proliferative arrest and apoptosis in malignant cells with short telomeres
    Meeting Abstract

    Wang, E. S.; Zhang, K.; Baksh, S.; Wu, K.; Gryaznov, S.; Chin, A.; Moore, M. A. S.
    Blood (2002)

    Fulltext@MSK | Save
  • PDX, a novel antifolate with potent in vitro and in vivo activity in non-Hodgkin's lymphoma
    Meeting Abstract

    Wang, E. S.; O'connor, O.; Zhang, K.; She, Y.; Zelenetz, A.; Sirotnak, F. M.; Moore, M. A. S.
    Blood (2001)

    Fulltext@MSK | Save